Device
Endoscopic hemostasis
Endoscopic hemostasis is a medical device with 3 clinical trials. Historical success rate of 50.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(33%)
Phase Distribution
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Terminated(1)
Other(1)
Detailed Status
Terminated1
Completed1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
terminated133%
completed133%
unknown133%
Recent Activity
0 active trials
Showing 3 of 3
completed
The Selection Criteria for the Second-look Endoscopy Among Patients With Bleeding Peptic Ulcers
NCT02197039
terminatednot_applicable
Early Endoscopy for Acute Upper Gastrointestinal Bleeding in Acute Coronary Syndrome Patients
NCT02618980
unknownnot_applicable
Endoscopic Treatment of Recurrent Upper GI Bleeding: OTSC [Over the Scope Clip] Versus Standard Therapy
NCT01836900
Clinical Trials (3)
Showing 3 of 3 trials
NCT02197039
The Selection Criteria for the Second-look Endoscopy Among Patients With Bleeding Peptic Ulcers
NCT02618980Not Applicable
Early Endoscopy for Acute Upper Gastrointestinal Bleeding in Acute Coronary Syndrome Patients
NCT01836900Not Applicable
Endoscopic Treatment of Recurrent Upper GI Bleeding: OTSC [Over the Scope Clip] Versus Standard Therapy
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3